Study Design and Rationale of "A Multicenter, Open-Labeled, Randomized Controlled Trial Comparing Three 2nd-Generation Drug-Eluting Stents in Real-World Practice" (CHOICE trial)
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Youn, Young Jin | - |
dc.contributor.author | Lee, Jun-Won | - |
dc.contributor.author | Ahn, Sung Gyun | - |
dc.contributor.author | Lee, Seung-Hwan | - |
dc.contributor.author | Choi, Hyun Hee | - |
dc.contributor.author | Choi, Hyunmin | - |
dc.contributor.author | Choi, Cheol Ung | - |
dc.contributor.author | Lee, Jin Bae | - |
dc.contributor.author | Cho, Jang Hyun | - |
dc.contributor.author | Kang, Tae Soo | - |
dc.contributor.author | Cho, Byung Ryul | - |
dc.contributor.author | Cha, Kwang Soo | - |
dc.contributor.author | Kim, Moo Hyun | - |
dc.contributor.author | Hyon, Min Su | - |
dc.contributor.author | Cheong, Sang-Sig | - |
dc.contributor.author | Lim, Do-Sun | - |
dc.contributor.author | Han, Kyoo Rok | - |
dc.contributor.author | Jeong, Myung Ho | - |
dc.contributor.author | Park, Keum Soo | - |
dc.contributor.author | Yoon, Junghan | - |
dc.date.accessioned | 2021-09-05T23:12:22Z | - |
dc.date.available | 2021-09-05T23:12:22Z | - |
dc.date.created | 2021-06-14 | - |
dc.date.issued | 2013-08 | - |
dc.identifier.issn | 0002-8703 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/102554 | - |
dc.description.abstract | Background The second-generation drug-eluting stents (DES) have shown superiority in many studies relating to safety and efficacy when compared with the first-generation DES. However, it is unclear whether there are differences in efficacy and safety among the second-generation DES after long-term follow-up. Methods This multicenter, prospective, randomized, open-labeled trial will directly compare the efficacy and safety among the patients treated with either everolimus-eluting stent (EES), zotarolimus-eluting stent with biolinx polymer (ZES-R), or biolimus-eluting stent (BES) with minimal exclusion criteria. The primary end point is a patient-oriented composite consisted of cardiac death, myocardial infarction not clearly attributable to a nontarget vessel and clinically indicated target lesion revascularization at 24-month clinical follow-up post-index procedure. With the hypothesis that "BES is non-inferior to EES" or "BES is non-inferior to ZES-R" in primary end point, approximately 2,600 patients will be assigned to one of the types of stents using a web-based randomization system. Conclusions The CHOICE trial will directly compare the efficacy and safety of EES, ZES-R, and BES in everyday clinical practice for long-term follow-up. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | MOSBY-ELSEVIER | - |
dc.subject | CORONARY-ARTERY-DISEASE | - |
dc.subject | DURABLE POLYMER | - |
dc.subject | BIODEGRADABLE POLYMER | - |
dc.subject | POOLED ANALYSIS | - |
dc.subject | FOLLOW-UP | - |
dc.subject | THROMBOSIS | - |
dc.subject | EVEROLIMUS | - |
dc.subject | LEADERS | - |
dc.subject | IMPLANTATION | - |
dc.subject | EFFICACY | - |
dc.title | Study Design and Rationale of "A Multicenter, Open-Labeled, Randomized Controlled Trial Comparing Three 2nd-Generation Drug-Eluting Stents in Real-World Practice" (CHOICE trial) | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Choi, Cheol Ung | - |
dc.contributor.affiliatedAuthor | Lim, Do-Sun | - |
dc.identifier.doi | 10.1016/j.ahj.2013.04.014 | - |
dc.identifier.scopusid | 2-s2.0-84880921623 | - |
dc.identifier.wosid | 000322629000006 | - |
dc.identifier.bibliographicCitation | AMERICAN HEART JOURNAL, v.166, no.2, pp.224 - 229 | - |
dc.relation.isPartOf | AMERICAN HEART JOURNAL | - |
dc.citation.title | AMERICAN HEART JOURNAL | - |
dc.citation.volume | 166 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 224 | - |
dc.citation.endPage | 229 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalWebOfScienceCategory | Cardiac & Cardiovascular Systems | - |
dc.subject.keywordPlus | CORONARY-ARTERY-DISEASE | - |
dc.subject.keywordPlus | DURABLE POLYMER | - |
dc.subject.keywordPlus | BIODEGRADABLE POLYMER | - |
dc.subject.keywordPlus | POOLED ANALYSIS | - |
dc.subject.keywordPlus | FOLLOW-UP | - |
dc.subject.keywordPlus | THROMBOSIS | - |
dc.subject.keywordPlus | EVEROLIMUS | - |
dc.subject.keywordPlus | LEADERS | - |
dc.subject.keywordPlus | IMPLANTATION | - |
dc.subject.keywordPlus | EFFICACY | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.